Marco Olivera

776 total citations
19 papers, 289 citations indexed

About

Marco Olivera is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Marco Olivera has authored 19 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Hepatology and 5 papers in Surgery. Recurrent topics in Marco Olivera's work include Liver Disease Diagnosis and Treatment (9 papers), Drug Transport and Resistance Mechanisms (5 papers) and Liver Diseases and Immunity (5 papers). Marco Olivera is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Drug Transport and Resistance Mechanisms (5 papers) and Liver Diseases and Immunity (5 papers). Marco Olivera collaborates with scholars based in United States, Mexico and Switzerland. Marco Olivera's co-authors include Sandeep Mukherjee, Yazen Alnouti, Sai Praneeth Bathena, Nagsen Gautam, Jane L. Meza, Rhishikesh Thakare, David Kershenobich, Timothy M. McCashland, Jawaher Abdullah Alamoudi and David F. Mercer and has published in prestigious journals such as Blood, Gastroenterology and Toxicological Sciences.

In The Last Decade

Marco Olivera

18 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Olivera United States	8	166	143	92	49	43	19	289
Bilgin Cömert Türkiye	12	76 0.5×	82 0.6×	201 2.2×	36 0.7×	45 1.0×	24	338
M Malavolti United States	11	136 0.8×	118 0.8×	175 1.9×	40 0.8×	52 1.2×	21	359
Yoo-Mee Vanwijngaerden Belgium	6	56 0.3×	97 0.7×	52 0.6×	39 0.8×	53 1.2×	6	257
Evelyn Zöhrer Austria	11	151 0.9×	165 1.2×	78 0.8×	12 0.2×	63 1.5×	12	331
David E. Hatoff United States	10	129 0.8×	111 0.8×	132 1.4×	56 1.1×	66 1.5×	12	349
Matthew D. Merrell United States	9	117 0.7×	152 1.1×	31 0.3×	108 2.2×	62 1.4×	11	343
Regina Maria Cubero Leitão Brazil	9	70 0.4×	93 0.7×	123 1.3×	60 1.2×	121 2.8×	23	320
Mayra Sanchez United States	6	174 1.0×	144 1.0×	99 1.1×	141 2.9×	105 2.4×	14	367
Jane A. Byrne United Kingdom	4	303 1.8×	94 0.7×	199 2.2×	92 1.9×	74 1.7×	5	394
Mari Thörn Sweden	9	109 0.7×	182 1.3×	82 0.9×	94 1.9×	7 0.2×	12	407

Countries citing papers authored by Marco Olivera

Since Specialization

Citations

This map shows the geographic impact of Marco Olivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Olivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Olivera more than expected).

Fields of papers citing papers by Marco Olivera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Olivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Olivera. The network helps show where Marco Olivera may publish in the future.

Co-authorship network of co-authors of Marco Olivera

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Olivera. A scholar is included among the top collaborators of Marco Olivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Olivera. Marco Olivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

García, Coralith, Fiorella Krapp, Marco Olivera, et al.. (2023). Antibiotic point prevalence survey and antimicrobial resistance in hospitalized patients across Peruvian reference hospitals. Journal of Infection and Public Health. 16. 52–60. 4 indexed citations

Alamoudi, Jawaher Abdullah, Nagsen Gautam, Marco Olivera, et al.. (2021). Bile acid indices as biomarkers for liver diseases I: Diagnostic markers. World Journal of Hepatology. 13(4). 433–455. 14 indexed citations

Alamoudi, Jawaher Abdullah, Nagsen Gautam, Marco Olivera, et al.. (2021). Bile acid indices as biomarkers for liver diseases II: The bile acid score survival prognostic model. World Journal of Hepatology. 13(5). 543–556. 5 indexed citations

Dhaliwal, Amaninder, et al.. (2020). Impact of sarcopenia on mortality in patients undergoing liver re-transplantation. World Journal of Hepatology. 12(10). 807–815. 8 indexed citations

Olivera, Marco, et al.. (2015). Situs inversus totalis and abdominal aortic aneurysm: Surgical repair of an extremely uncommon association. International Journal of Surgery Case Reports. 10. 216–218. 5 indexed citations

Gundabolu, Krishna, Vijaya Raj Bhatt, Lori J. Maness, et al.. (2015). Predisposition to Budd-Chiari Syndrome: A Single-Center Case Series of a Rare Subset of Venous Thromboembolism. Blood. 126(23). 4719–4719.

Bathena, Sai Praneeth, Rhishikesh Thakare, Nagsen Gautam, et al.. (2014). Urinary Bile Acids as Biomarkers for Liver Diseases II. Signature Profiles in Patients. Toxicological Sciences. 143(2). 308–318. 38 indexed citations

Bathena, Sai Praneeth, Rhishikesh Thakare, Nagsen Gautam, et al.. (2014). Urinary Bile Acids as Biomarkers for Liver Diseases I. Stability of the Baseline Profile in Healthy Subjects. Toxicological Sciences. 143(2). 296–307. 47 indexed citations

Bathena, Sai Praneeth, Sandeep Mukherjee, Marco Olivera, & Yazen Alnouti. (2013). The profile of bile acids and their sulfate metabolites in human urine and serum. Journal of Chromatography B. 942-943. 53–62. 108 indexed citations

10.

Kalil, André C., Cezarina Mindru, Jean Botha, et al.. (2012). Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir prophylaxis: A systematic review and meta-analysis. Liver Transplantation. 18(12). 1440–1447. 23 indexed citations

11.

Mercado, Miguel Ángel, et al.. (2009). Intrahepatic Bilioenteric Anastomosis After Biliary Complications of Liver Transplantation: Operative Rescue of Surgical Failures. World Journal of Surgery. 33(3). 534–538. 5 indexed citations

12.

Gallegos‐Orozco, Juan F., Ana Fuentes, R. Rodríguez, et al.. (2005). Early hepatitis C virus changes and sustained response in patients with chronic hepatitis C treated with peginterferon α‐2b and ribavirin. Liver International. 25(1). 91–95. 7 indexed citations

13.

Chan, Carlos H.F., et al.. (2003). "Programa de Trasplante Hepático en el Instituto Nacional de Ciencias Médicas y Nutrición ""Salvador Zubirán""". Revista Portuguesa de Pneumologia. 68. 83–86. 1 indexed citations

14.

Olivera, Marco & David Kershenobich. (1999). Pyogenic liver abscess. Current Treatment Options in Gastroenterology. 2(2). 86–90. 12 indexed citations

15.

Olivera, Marco, et al.. (1998). Mayo risk score is not predictive of cholangiocarcinoma associated with primary sclerosing cholangitis. Gastroenterology. 114. A1316–A1316. 1 indexed citations

16.

Olivera, Marco, et al.. (1996). Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients.. PubMed. 28(6). 3348–50. 1 indexed citations

17.

Olivera, Marco, et al.. (1994). [Non-alcoholic fatty liver: 10 years' experience at the Insituto Nacional de la Nutrición Salvador Zubirán].. PubMed. 46(2). 85–92. 3 indexed citations

18.

Olivera, Marco, Mariana J. Kaplan, Juan R. Bobadilla, et al.. (1994). [Prevalence of antinuclear antibodies in primary biliary cirrhosis, with negative antimitochondrial antibodies].. PubMed. 58(3). 220–2. 1 indexed citations

19.

Olivera, Marco, et al.. (1991). [A 10-year prolective study on cancer of the digestive system].. PubMed. 55(1). 17–24. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact